Trump reaches deal with AstraZeneca to lower U.S. drug prices, MSNBC reports
1. AstraZeneca to cut drug prices in U.S. as part of new agreement. 2. Deal includes selling drugs at lowest prices to Medicaid patients. 3. Company committed to invest $50 billion in U.S. by 2030. 4. Similar agreements previously made with Pfizer under Trump administration. 5. Future tariff threats on non-compliant drugmakers emphasized by Trump.